Back
Reshape Lifesciences Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
28
RSLS
Reshape Lifesciences
Last Price:
5.38
Seasonality Move:
38.21%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeReshape Lifesciences Price Quote
$5.38
-0.28 (-4.95%)
(Updated: November 12, 2024 at 5:40 PM ET)
Reshape Lifesciences Key Stats
Sell
28
Reshape Lifesciences (RSLS)
is a Sell
Day range:
$4.88 - $6.00
52-week range:
$4.60 - $34.22
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.23
P/B ratio:
0.95%
Volume:
1.3M
Avg. volume:
151.4K
1-year change:
-59.42%
Market cap:
$2.9M
Revenue:
$8.7M
EPS:
$-72.06
How Much Does Reshape Lifesciences Make?
-
How Much Are Reshape Lifesciences's Sales Annually?
RSLS Revenues are $8.7M -
How Much Profit Does Reshape Lifesciences's Make A Year?
RSLS net income is -$11.4M
Is Reshape Lifesciences Growing As A Company?
-
What Is Reshape Lifesciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.13% -
What Is Reshape Lifesciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Reshape Lifesciences Stock Price Performance
-
Did Reshape Lifesciences Stock Go Up Last Month?
Reshape Lifesciences share price went up by 11.42% last month -
Did RSLS's Share Price Rise Over The Last Year?
RSLS share price fell by -59.42% over the past 1 year
What Is Reshape Lifesciences 52-Week High & Low?
-
What Is Reshape Lifesciences’s 52-Week High Share Price?
Reshape Lifesciences has traded as high as $34.22 over the past 52 weeks -
What Is Reshape Lifesciences’s 52-Week Low Share Price?
Reshape Lifesciences has traded as low as $4.60 over the past 52 weeks
Reshape Lifesciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Reshape Lifesciences?
-
How Much Debt Does Reshape Lifesciences Have?
Total long term debt quarterly is $0 -
How Much Cash Does Reshape Lifesciences Have?
Cash and short term investments quarterly total is $1.1M -
What Is Reshape Lifesciences’s Book Value Per Share?
Book value per share is 5.99
Is Reshape Lifesciences Cash Flow Positive?
-
What Is RSLS Cash Flow From Operations?
Cash flow from operations (TTM) is -$8.7M -
What Is Reshape Lifesciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5.1M -
What Is Reshape Lifesciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Reshape Lifesciences Return On Invested Capital
-
Is Management Doing A Good Job?
RSLS return on invested capital is -187.5% -
What Is Reshape Lifesciences Return On Assets?
ROA measures how assets are converting to revenues and is -100.3% -
What Is RSLS Return On Equity?
ROE is a measure of profitability and is -187.5%
Reshape Lifesciences Earnings Date & Stock Price
-
What Is Reshape Lifesciences's Stock Price Today?
A single share of RSLS can be purchased today for 5.66 -
What Is Reshape Lifesciences’s Stock Symbol?
Reshape Lifesciences trades on the nasdaq under the ticker symbol: RSLS -
When Is Reshape Lifesciences’s Next Earnings Date?
The next quarterly earnings date for Reshape Lifesciences is scheduled on November 15, 2024 -
When Is RSLS's next ex-dividend date?
Reshape Lifesciences's next ex-dividend date is November 12, 2024 -
How To Buy Reshape Lifesciences Stock?
You can buy Reshape Lifesciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Reshape Lifesciences Competitors
-
Who Are Reshape Lifesciences's Competitors?
Below is a list of companies who compete with Reshape Lifesciences or are related in some way:
Reshape Lifesciences Dividend Yield
-
What Is RSLS Dividend Yield?
Reshape Lifesciences’s dividend yield currently is 0% -
What Is Reshape Lifesciences’s Payout Ratio?
Reshape Lifesciences’s payout ratio is 0% -
When Did Reshape Lifesciences Last Pay A Dividend?
The latest dividend pay date is November 12, 2024 -
What Is Reshape Lifesciences’s Dividend Per Share?
Reshape Lifesciences pays a dividend of $0.00 per share
Reshape Lifesciences Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 41% |
| Revenue: | -12.82% | -7.61% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 58.00 |
| Upside from Last Price: | 924.73% |